1. Home
  2. LXRX vs ALDF Comparison

LXRX vs ALDF Comparison

Compare LXRX & ALDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • ALDF
  • Stock Information
  • Founded
  • LXRX 1995
  • ALDF 2024
  • Country
  • LXRX United States
  • ALDF United States
  • Employees
  • LXRX N/A
  • ALDF N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • ALDF
  • Sector
  • LXRX Health Care
  • ALDF
  • Exchange
  • LXRX Nasdaq
  • ALDF NYSE
  • Market Cap
  • LXRX 273.9M
  • ALDF 296.6M
  • IPO Year
  • LXRX 2000
  • ALDF 2024
  • Fundamental
  • Price
  • LXRX $0.69
  • ALDF $9.95
  • Analyst Decision
  • LXRX Buy
  • ALDF
  • Analyst Count
  • LXRX 2
  • ALDF 0
  • Target Price
  • LXRX $6.00
  • ALDF N/A
  • AVG Volume (30 Days)
  • LXRX 5.0M
  • ALDF 9.4K
  • Earning Date
  • LXRX 03-10-2025
  • ALDF 01-01-0001
  • Dividend Yield
  • LXRX N/A
  • ALDF N/A
  • EPS Growth
  • LXRX N/A
  • ALDF N/A
  • EPS
  • LXRX N/A
  • ALDF N/A
  • Revenue
  • LXRX $5,229,000.00
  • ALDF N/A
  • Revenue This Year
  • LXRX $842.94
  • ALDF N/A
  • Revenue Next Year
  • LXRX $19.76
  • ALDF N/A
  • P/E Ratio
  • LXRX N/A
  • ALDF N/A
  • Revenue Growth
  • LXRX 886.60
  • ALDF N/A
  • 52 Week Low
  • LXRX $0.62
  • ALDF $9.98
  • 52 Week High
  • LXRX $3.73
  • ALDF $11.46
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 40.93
  • ALDF N/A
  • Support Level
  • LXRX $0.70
  • ALDF N/A
  • Resistance Level
  • LXRX $0.75
  • ALDF N/A
  • Average True Range (ATR)
  • LXRX 0.08
  • ALDF 0.00
  • MACD
  • LXRX -0.00
  • ALDF 0.00
  • Stochastic Oscillator
  • LXRX 7.14
  • ALDF 0.00

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

About ALDF ALDEL FINL II INC

Aldel Financial II Inc is a blank check company.

Share on Social Networks: